# Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission

> **NCT01575613** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 17506 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine combination
- **BIOLOGICAL:** Bacillus thuringiensis
- **BIOLOGICAL:** Long lasting insecticide treated net (LLINs)
- **BIOLOGICAL:** Indoor Residual Spraying (IRS)

## Key facts

- **NCT ID:** NCT01575613
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 17506 (ACTUAL)
- **Last updated:** 2012-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01575613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01575613, "Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01575613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*